Skip to main content

Advertisement

SpringerLink
Log in

Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

Vanishing white matter (VWM) is one of the most prevalent leukoencephalopathies and is caused by recessive mutations in gene eIF2B1–5. The onset may vary from an antenatal disorder that is rapidly fatal to an adult-onset disorder with chronic progressive deterioration.

Methods

Based on a comprehensive study of 14 juvenile/adult patients diagnosed in our department as well as a review of 71 previously reported cases of genetically confirmed juvenile/adult-onset VWM since 2001, we attempted to delineate the clinical symptoms, disease evolution, episodic aggravation, associated symptoms, MRI findings and genotypic characteristics of adult VWM.

Results

The onset age of neuropsychiatric symptoms was 23.4 ± 10.6 years, and the mean follow-up time was 8.1 ± 4.8 years. Major clinical symptoms included headache, epilepsy, cognitive decline, cerebellar ataxia, and urinary disturbances. Episodic aggravation was found in 42.9% of the patients in our series. Molecular studies revealed fourteen novel missense mutations. Diffuse abnormal signals characterized by T1-weighted hypointensity and T2-weighted hyperintensity were observed in the supratentorial white matter.

Conclusions

The symmetrical leukoencephalopathy must be considered in patients of any age with premature ovarian failure or optic neuropathy. The VWM disease spectrum consists of characteristic imaging findings in combination with extremely wide variability in VWM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The data used to support the findings of this study are available from the corresponding author upon request and all data were presented in Table 1, 2, 3, 4, 5, 6, and 7.

References

  1. Vermeulen G, Seidl R, Mercimek-Mahmutoglu S, Rotteveel JJ, Scheper GC, van der Knaap MS (2005) Fright is a provoking factor in vanishing white matter disease. Ann Neurol 57:560–563

    Article  PubMed  Google Scholar 

  2. Scali O, Di Perri C, Federico A (2006) The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol Sci 27:271–277

    Article  CAS  PubMed  Google Scholar 

  3. Bugiani M, Vuong C, Breur M, van der Knaap MS (2018) Vanishing white matter: a leukodystrophy due to astrocytic dysfunction. Brain Pathol 28:408–421

    Article  PubMed  PubMed Central  Google Scholar 

  4. Keefe MD, Soderholm HE, Shih HY, Stevenson TJ, Glaittli KA, Bowles DM, Scholl E, Colby S, Merchant S, Hsu EW, Bonkowsky JL (2020) Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response. Elife 10(9):e56319

  5. Leferink PS, Breeuwsma N, Bugiani M, van der Knaap MS, Heine VM (2018) Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter. Glia 66:862–873

    Article  PubMed  Google Scholar 

  6. Fogli A, Dionisi-Vici C, Deodato F, Bartuli A, Boespflug-Tanguy O, Bertini E (2002) A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation. Neurology 59:1966–1968

    Article  CAS  PubMed  Google Scholar 

  7. van der Knaap MS, van Berkel CG, Herms J, van Coster R, Baethmann M, Naidu S, Boltshauser E, Willemsen MA, Plecko B, Hoffmann GF, Proud CG, Scheper GC, Pronk JC (2003) eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet 73:1199–1207

    Article  PubMed  PubMed Central  Google Scholar 

  8. van der Knaap MS, Barth PG, Gabreels FJ, Franzoni E, Begeer JH, Stroink H, Rotteveel JJ, Valk J (1997) A new leukoencephalopathy with vanishing white matter. Neurology 48:845–855

    Article  PubMed  Google Scholar 

  9. Labauge P, Horzinski L, Ayrignac X, Blanc P, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Fogli A, Boespflug-Tanguy O (2009) Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 132:2161–2169

    Article  PubMed  Google Scholar 

  10. Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Sedel F, Guennoc AM, Sartori E, Laplaud D, Antoine JC, Fogli A, Boespflug-Tanguy O, Labauge P (2011) Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases. Rev Neurol (Paris) 167:802–811

    Article  CAS  Google Scholar 

  11. Hamilton EMC, van der Lei HDW, Vermeulen G, Gerver JAM, Lourenco CM, Naidu S, Mierzewska H, Gemke R, de Vet HCW, Uitdehaag BMJ, Lissenberg-Witte BI, Research Group V, van der Knaap MS (2018) Natural history of vanishing white matter. Annals Neurol 84:274–288

    Article  Google Scholar 

  12. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424

    Article  PubMed  PubMed Central  Google Scholar 

  13. Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O (2003) Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 72:1544–1550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ohtake H, Shimohata T, Terajima K, Kimura T, Jo R, Kaseda R, Iizuka O, Takano M, Akaiwa Y, Goto H, Kobayashi H, Sugai T, Muratake T, Hosoki T, Shioiri T, Okamoto K, Onodera O, Tanaka K, Someya T, Nakada T, Tsuji S (2004) Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5. Neurology 62:1601–1603

    Article  CAS  PubMed  Google Scholar 

  15. Ohlenbusch A, Henneke M, Brockmann K, Goerg M, Hanefeld F, Kohlschutter A, Gartner J (2005) Identification of ten novel mutations in patients with eIF2B-related disorders. Hum Mutat 25:411

    Article  PubMed  Google Scholar 

  16. Peter L, Niel F, Catenoix H, Jung J, Demarquay G, Petiot P, Rudigoz RC, Boespflug-Tanguy O, Ryvlin P, Mauguiere F (2008) Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor. Eur J Neurol 15:94–97

    Article  CAS  PubMed  Google Scholar 

  17. Lee HN, Koh SH, Lee KY, Ki CS, Lee YJ (2009) Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations. Eur J Neurol 16:e42-43

    Article  PubMed  Google Scholar 

  18. Matsukawa T, Wang X, Liu R, Wortham NC, Onuki Y, Kubota A, Hida A, Kowa H, Fukuda Y, Ishiura H, Mitsui J, Takahashi Y, Aoki S, Takizawa S, Shimizu J, Goto J, Proud CG, Tsuji S (2011) Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5. Neurogenetics 12:259–261

    Article  PubMed  Google Scholar 

  19. Ghezzi L, Scarpini E, Rango M, Arighi A, Bassi MT, Tenderini E, De Riz M, Jacini F, Fumagalli GG, Pietroboni AM, Galimberti D, Bresolin N (2012) A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation. Neurology 79:2077–2078

    Article  PubMed  Google Scholar 

  20. La Piana R, Vanderver A, van der Knaap M, Roux L, Tampieri D, Brais B, Bernard G (2012) Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation. Arch Neurol 69:765–768

    Article  PubMed  PubMed Central  Google Scholar 

  21. van der Lei HD, Steenweg ME, Bugiani M, Pouwels PJ, Vent IM, Barkhof F, van Wieringen WN, van der Knaap MS (2012) Restricted diffusion in vanishing white matter. Arch Neurol 69:723–727

    PubMed  Google Scholar 

  22. Valalik I, van der Knaap MS, Scheper GC, Jobbagy A, Liptai Z, Csokay A (2012) Long-term tremor control with bilateral Vim-DBS in vanishing white matter disease. Parkinsonism Relat Disord 18:1048–1050

    Article  PubMed  Google Scholar 

  23. Zhang H, Dai L, Chen N, Zang L, Leng X, Du L, Wang J, Jiang Y, Zhang F, Wu X, Wu Y (2015) Fifteen novel EIF2B1–5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up. PLoS One 10:e0118001

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Shimada S, Shimojima K, Sangu N, Hoshino A, Hachiya Y, Ohto T, Hashi Y, Nishida K, Mitani M, Kinjo S, Tsurusaki Y, Matsumoto N, Morimoto M, Yamamoto T (2015) Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease. Brain Dev 37:960–966

    Article  PubMed  Google Scholar 

  25. Ibitoye RT, Renowden SA, Faulkner HJ, Scolding NJ, Rice CM (2016) Ovarioleukodystrophy due to EIF2B5 mutations. Pract Neurol 16:496–499

    Article  CAS  PubMed  Google Scholar 

  26. Lynch DS, Rodrigues Brandao de Paiva A, Zhang WJ, Bugiardini E, Freua F, Tavares Lucato L, Macedo-Souza LI, Lakshmanan R, Kinsella JA, Merwick A, Rossor AM, Bajaj N, Herron B, McMonagle P, Morrison PJ, Hughes D, Pittman A, Laura M, Reilly MM, Warren JD, Mummery CJ, Schott JM, Adams M, Fox NC, Murphy  

  27. Humayun M, Khan A (2018) Case Report: Cerebral leukodystrophy and the gonadal endocrinopathy: a rare but real association. F1000Res 7:158

    Article  PubMed  PubMed Central  Google Scholar 

  28. Villar-Quiles RN, Delgado-Suarez C, Jorquera-Moya M, Arpa-Gutierrez J, Ortega-Suero G (2018) Teaching NeuroImages: Adult-onset vanishing white matter disease. Neurology 90:e1091–e1092

    Article  PubMed  Google Scholar 

  29. Barros SR, Parreira SCR, Miranda AFB, Pereira AMB, Campos NMP (2018) New Insights in Vanishing White Matter Disease: Isolated Bilateral Optic Neuropathy in Adult Onset Disease. J Neuroophthalmol 38:42–46

    Article  PubMed  Google Scholar 

  30. Accogli A, Brais B, Tampieri D, La Piana R (2019) Long-standing psychiatric features as the only clinical presentation of vanishing white matter disease. J Neuropsychiatry Clin Neurosci 31:276–279

  31. Trevisan L, Grazzini M, Cianflone A, Accogli A, Finocchi C, Capello E, Saitta L, Grandis M, Roccatagliata L, Mandich P (2021) An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and EIF2B5 mutations. A case report. Neurocase 27:452–456

  32. Xu L, Zhong M, Yang Y, Wang M, An N, Xu X, Zhu Y, Li Z, Chen H, Zhao R, Zheng X (2022) Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis. Neurol Sci 43:2659–2667

  33. Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS (2010) Leukoencephalopathy with vanishing white matter: a review. J Neuropathol Exp Neurol 69:987–996

    Article  PubMed  Google Scholar 

  34. Spilka R, Ernst C, Bergler H, Rainer J, Flechsig S, Vogetseder A, Lederer E, Benesch M, Brunner A, Geley S, Eger A, Bachmann F, Doppler W, Obrist P, Haybaeck J (2014) eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation. Cell Oncol (Dordr) 37:253–267

    Article  CAS  Google Scholar 

  35. Abbink TEM, Wisse LE, Jaku E, Thiecke MJ, Voltolini-Gonzalez D, Fritsen H, Bobeldijk S, Ter Braak TJ, Polder E, Postma NL, Bugiani M, Struijs EA, Verheijen M, Straat N, van der Sluis S, Thomas AAM, Molenaar D, van der Knaap MS (2019) Vanishing white matter: deregulated integrated stress response as therapy target. Ann Clin Transl Neurol 6:1407–1422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS (2001) Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 29:383–388

    Article  CAS  PubMed  Google Scholar 

  37. van der Knaap MS, Leegwater PA, Konst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC (2002) Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 51:264–270

    Article  PubMed  CAS  Google Scholar 

  38. Huber T, Herwerth M, Alberts E, Kirschke JS, Zimmer C, Ilg R (2017) Automated segmentation reveals silent radiographic progression in adult-onset vanishing white-matter disease. Neuroradiol J 30:5–9

    Article  PubMed  Google Scholar 

  39. Fogli A, Boespflug-Tanguy O (2006) The large spectrum of eIF2B-related diseases. Biochem Soc Trans 34:22–29

    Article  CAS  PubMed  Google Scholar 

  40. Mierzewska H, van der Knaap MS, Scheper GC, Jurkiewicz E, Schmidt-Sidor B, Szymanska K (2006) Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation First Polish cases. Folia Neuropathol 44:144–148

    CAS  PubMed  Google Scholar 

  41. Klingelhoefer L, Misbahuddin A, Jawad T, Mellers J, Jarosz J, Weeks R, Ray Chaudhuri K (2014) Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood–a case report and review of the literature. Pediatr Neurol 51:157–164

    Article  PubMed  Google Scholar 

  42. Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, Suhr D, Waggoner J, Hobson D, Vanderver A, Patterson MC, Consortium G (2015) Consensus statement on preventive and symptomatic care of leukodystrophy patients. Mol Genet Metab 114:516–526

    Article  PubMed  CAS  Google Scholar 

  43. Stellingwerff MD, Al-Saady ML, van de Brug T, Barkhof F, Pouwels PJW, van der Knaap MS (2021) MRI natural history of the leukodystrophy vanishing white matter. Radiology 300:671–680

    Article  PubMed  Google Scholar 

  44. Wu Y, Pan Y, Du L, Wang J, Gu Q, Gao Z, Li J, Leng X, Qin J, Wu X, Jiang Y (2009) Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease. J Hum Genet 54:74–77

    Article  CAS  PubMed  Google Scholar 

  45. Slynko I, Nguyen S, Hamilton EMC, Wisse LE, de Esch IJP, de Graaf C, Bruning JB, Proud CG, Abbink TEM, van der Knaap MS (2021) Vanishing white matter: eukaryotic initiation factor 2B model and the impact of missense mutations. Mol Genet Genomic Med 9:e1593

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Deng J, Zhou L, Zhang J, Chang X, Jiang Y, Wang J, Wu Y (2021) Correlation between genotype and age of onset in leukoencephalopathy with vanishing white matter. Front Genet 12:729777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Maletkovic J, Schiffmann R, Gorospe JR, Gordon ES, Mintz M, Hoffman EP, Alper G, Lynch DR, Singhal BS, Harding C, Amartino H, Brown CM, Chan A, Renaud D, Geraghty M, Jensen L, Senbil N, Kadom N, Nazarian J, Yuanjian F, Zuyi W, Hartka T, Morizono H, Vanderver A (2008) Genetic and clinical heterogeneity in eIF2B-related disorder. J Child Neurol 23:205–215

    Article  PubMed  Google Scholar 

  48. Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O (2004) Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet 12:561–566

    Article  CAS  PubMed  Google Scholar 

  49. Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu MP, Rodriguez D, Boespflug-Tanguy O (2004) The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 62:1509–1517

    Article  CAS  PubMed  Google Scholar 

  50. Singh RR, Livingston J, Lim M, Berry IR, Siddiqui A (2017) An unusual neuroimaging finding and response to immunotherapy in a child with genetically confirmed vanishing white matter disease. Eur J Paediatr Neurol 21:410–413

    Article  PubMed  Google Scholar 

  51. Zhou L, Li P, Chen N, Dai LF, Gao K, Liu YN, Shen L, Wang JM, Jiang YW, Wu Y (2019) Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction. CNS Neurosci Ther 25:759–771

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Wong YL, LeBon L, Basso AM, Kohlhaas KL, Nikkel AL, Robb HM, Donnelly-Roberts DL, Prakash J, Swensen AM, Rubinstein ND, Krishnan S, McAllister FE, Haste NV, O'Brien JJ, Roy M, Ireland A, Frost JM, Shi L, Riedmaier S, Martin K, Dart MJ, Sidrauski C (2019) eIF2B activator prevents neurological defects caused by a chronic integrated stress response. Elife 9(8):e42940

  53. Dooves S, Leferink PS, Krabbenborg S, Breeuwsma N, Bots S, Hillen AEJ, Jacobs G, van der Knaap MS, Heine VM (2019) Cell replacement therapy improves pathological hallmarks in a mouse model of leukodystrophy vanishing white matter. Stem Cell Reports 12:441–450

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Lingtao Zhan and Running Gene Inc. for performing next-generation Sequencing and Sanger Sequencing. We are also grateful to the patients and the patients’ family members for their participation in this study.

Author information

Authors and Affiliations

  1. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China

    Yuting Ren, Xueying Yu, Bin Chen, Hefei Tang, Songtao Niu, Xingao Wang, Hua Pan & Zaiqiang Zhang

Authors
  1. Yuting Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xueying Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hefei Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Songtao Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xingao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hua Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zaiqiang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zaiqiang Zhang.

Ethics declarations

Ethical approval

None.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ren, Y., Yu, X., Chen, B. et al. Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients. Neurol Sci 43, 4961–4977 (2022). https://doi.org/10.1007/s10072-022-06011-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-022-06011-0

Keywords

Search

Navigation